Amyloidosis Research Consortium (ARC)
Kevin Palmer is the Director of Finance and Operations at the Amyloidosis Research Consortium (ARC) since February 2023. Previously, Kevin held multiple leadership roles at Annkissam from January 2015 to May 2022, including Managing Director of Self-Direction, Chief Executive Officer, and Chief Operating Officer, focusing on providing software solutions for Home and Community-Based Services. Earlier in Kevin's career, leadership experience was gained at AmeriCorps VISTA from June 2006 to September 2008 as a VISTA Leader and School Program Lead at HOME, Inc. Kevin holds a Bachelor's degree from Ithaca College, earned between January 2002 and January 2006.
This person is not in any teams
This person is not in any offices
Amyloidosis Research Consortium (ARC)
The Amyloidosis Research Consortium (ARC) addresses critical needs in clinical trials and related research for the underserved group of systemic amyloid diseases. We have created a collaborative research model to bring together experts in the field to address the challenges that exist in developing diagnostic tools and to carrying out innovative clinical trials. Stay up to date with the latest news and research from ARC's newsletter: http://www.arci.org/newsletter-sign-up ARC is committed to building collaborative relationships between patients, academia, industry, foundations, federal funders, and regulators to advance the best research and speed new therapies to market. ARC is focused on increasing the amount of research and building a prioritized portfolio of translational research and clinical research. The work of the Amyloidosis Research Consortium has been made possible through the generous support of our donors. With continued funding of our strategic and vital research programs, you are investing in a promising future for amyloidosis patients. You can donate here: www.arci.org/donate